LOS ANGELES--(BUSINESS WIRE)--Remedy Place, the world’s first Social Wellness Club™ pioneering self-care and providing a healthier way to socialize, is pleased to announce the appointment of ...

Man and colleagues, in a case series of 5 patients whose histories were suggestive of photoinduced flares, described the development of biopsy-proven dyshidrosis after provocative exposure to ...

When itch is a sign of liver disease, the itch often starts on the palms and soles and spreads to other parts of the body. How to get relief: Getting an accurate diagnosis and treatment may relieve ...

Though effective, some people find this method uncomfortable. Some home remedies may offer benefits. Here are six alternative treatments to reduce sleep apnea symptoms. Maintaining a healthy ...

A mustard plaster, or mustard pack, is a home remedy believed to ease symptoms of respiratory conditions. However, there’s no evidence that mustard plasters work. The treatment may also cause ...

While viral infections will clear on their own, bacterial tonsillitis might require antibiotics. However, there are some evidence-based home remedies that can help ease or treat uncomfortable symptoms ...

Join the Decluttering Cure Community The home you love starts here The home you love starts here The wordmark for the Apartment Therapy brand. The logomark and logotype for the Apartment Therapy brand ...

Sept. 17, 2024 – The FDA has approved a new treatment for persistent eczema called Ebglyss that eventually only needs to be taken once per month, offering a less frequent maintenance dose ...

Ebglyss is a new biologic treatment for moderate-to-severe eczema that isn’t controlled with topical therapies. The medication is for adults and children 12 and older. In studies, people saw ...

Lilly hopes to challenge Regeneron and Sanofi’s dominant IL-4/IL-13 treatment in the indication, Dupixent. Another IL-13 on the market for AD is Leo Pharma’s Adbry, which was launched in 2022.

The FDA has approved an Eli Lilly drug that offers a new biologic treatment option with a dosing schedule that’s less burdensome for patients. The regulatory decision announced late Friday ...